Literature DB >> 11112447

Transcriptional activity of the distal CD40 ligand promoter.

F M Lobo1, S Xu, C Lee, R L Fuleihan.   

Abstract

CD40 ligand (CD40L, CD154) is a T cell cytokine with highly regulated expression that requires the transcription factor nuclear factor of activated T cells (NF-AT) to bind at two sites in the proximal CD40L promoter. We have determined that the distal CD40L promoter (-500 to -1300 bp from start of transcription) conveys superior promoter activity in reporter gene assays. Within the distal promoter, we have identified a third NF-AT binding site, at -761 to -756. Oligonucleotides incorporating each of the three NF-AT sites cross-compete for binding of nuclear extracts from activated T cells and bind NF-ATc2 by antibody supershift. Mutation of the distal NF-AT site reduces activity of the 1300 bp CD40L promoter construct to that of the proximal 500 bp construct, which includes only two NF-AT sites. This suggests that the newly identified NF-AT site is the major mediator of transcriptional activation in the distal CD40L promoter. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112447     DOI: 10.1006/bbrc.2000.3914

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Early growth response-1 is required for CD154 transcription.

Authors:  Randy Q Cron; Rupa Bandyopadhyay; Anna Genin; Michael Brunner; Gilbert J Kersh; Jiyi Yin; Terri H Finkel; Mary K Crow
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.

Authors:  Nicole S Harhaj; Branislava Janic; Juan C Ramos; William J Harrington; Edward W Harhaj
Journal:  Virology       Date:  2007-01-26       Impact factor: 3.616

3.  Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.

Authors:  Chongmin Huan; Matthew L Kelly; Ryan Steele; Iuliana Shapira; Susan R S Gottesman; Christopher A J Roman
Journal:  Nat Immunol       Date:  2006-08-27       Impact factor: 25.606

4.  Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.

Authors:  Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Yen-Chiu Lin-Lee; Richard J Ford
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

5.  Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.

Authors:  Erna Van Hoeyveld; Ping-Xia Zhang; Kris De Boeck; Ramsay Fuleihan; Xavier Bossuyt
Journal:  Immunology       Date:  2007-01-17       Impact factor: 7.397

Review 6.  CD154 transcriptional regulation in primary human CD4 T cells.

Authors:  Randy Q Cron
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.

Authors:  Hanen Ouadani; Imen Ben-Mustapha; Meriem Ben-ali; Leila Ben-khemis; Beya Larguèche; Raoudha Boussoffara; Sonia Maalej; Ilhem Fetni; Saida Hassayoun; Abdelmajid Mahfoudh; Fethi Mellouli; Sadok Yalaoui; Hatem Masmoudi; Mohamed Bejaoui; Mohamed-Ridha Barbouche
Journal:  Immunogenetics       Date:  2015-11-06       Impact factor: 2.846

8.  Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.

Authors:  Scott A Crist; Daniel L Sprague; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-07       Impact factor: 22.113

9.  Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-01       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.